Safely Sedating Children and Adolescents Who Are Neurodivergent
View abstract on PubMed
Summary
This summary is machine-generated.Neurodivergent children face unique medical sedation challenges. Individualized care, nonpharmacologic strategies, and tailored environments are crucial for safe and effective sedation.
Area Of Science
- Pediatric Medicine
- Neurodevelopmental Disorders
- Medical Sedation
Background
- Neurodivergent children experience higher injury rates and healthcare utilization.
- Sedation in neurodivergent youth presents unique challenges, including adverse event risks and behavioral complexities.
Purpose Of The Study
- To address the challenges of sedation for neurodivergent children.
- To highlight the need for individualized sedation planning and improved clinical guidelines.
Main Methods
- Review of existing literature and clinical practices regarding sedation in neurodivergent populations.
- Emphasis on individualized planning, agent selection, and nonpharmacologic adjuncts.
Main Results
- Sedation practices for neurodivergent children show significant variability.
- Individualized approaches considering sensory sensitivities and communication needs are vital.
Conclusions
- Tailored environmental modifications, communication strategies, and caregiver involvement enhance sedation safety.
- Future research should focus on patient-centered care, neurodivergent-friendly settings, and standardized protocols for equitable care.
Related Concept Videos
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...

